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Mutants of Herpes Simplex Virus Types 1 and 2 that are Resistant to Phosphonoacetic Acid Induce Altered DNA Polymerase Activities in Infected Cells
(Accepted I2 December I975) SUMMARY Three mutants of herpes simplex virus (HSV) have been isolated which form plaques in the presence of Ioo#g/ml phosphonoacetic acid (PPA). All three mutants (3 from HSV-I strain I7 syn +, I4 from HSV-I strain 17 syn, and I9 from HSV-2) induce viral DNA synthesis and viral DNA polymerase activity, and these are much less sensitive to PPA than the wild-type virus. The results support the hypothesis that PPA interacts directly with the viral DNA polymerase protein, at least part of which is virus coded.
Phosphonoacetic acid (PPA) has been shown to be a potent inhibitor of herpes simplex virus (HSV) growth, both in tissue culture and in infected animals (Shipkowitz et al. I973; Overby et aL 1974) . These studies suggested that an event late in the infectious cycle was affected, probably the synthesis of viral DNA. Subsequent work from the same laboratory (Mao, Robishaw & Overby, 1975) has confirmed and extended the above observations; the DNA polymerase activity induced in WI38 cells by herpes simplex virus type 1 (HSV-0 is strongly inhibited in vitro by low levels of PPA. In contrast, DNA polymerase preparations from uninfected WI38 cells appeared to be resistant to the inhibitor.
A spectrum of temperature-sensitive mutants of HSV unable to produce viral DNA at a non-permissive temperature has been analysed and mutants have been identified which indicate that the virus-induced DNA polymerase activity is, at least in part, virus-coded and is necessary for successful infection (Aron, Purifoy & Schaffer, I975; Crombie, I975; Hay et al. 1975; Purifoy & Benyesh-Melnick, 1975) .
This suggested that it was worth attempting to isolate HSV-1 and HSV-z mutants able to grow in the presence of PPA. If the above conclusions are valid, such mutants should induce a changed DNA polymerase activity more or less resistant to the inhibitor and capable of synthesising viral DNA in the presence of concentrations of PPA which would inhibit viral DNA synthesis by the wild type enzyme.
Wild-type stocks of HSV-I (strain I7) and HSV-2 (strain HG52) were tested by plaque assay (Russell, ~962) for sensitivity to PPA at medium concentrations of up to 3oo/zg[ml. At Ioo #g PPA/ml a lOOO-to IOOOO-fold fall in titre was observed for both HSV-I and HSV-2, the latter being slightly more resistant. At higher PPA concentrations than 25o to 3oo/zg/ml, the cells (BHK 2I/CI3) detached from their growth surface and died before plaques could be scored. Several other cell lines were tested (BS-C-I, RITA and PyY derivatives) and in the presence of high levels of PPA showed giant cell formation and other gross morphological changes with eventual loss of viability. Both virus types were therefore plated for plaque assay at IO 3, lO 4 and lO s p.f.u./5o mm Petri dish in the presence of Ioo/zg/ml PPA at 37 °C. Both the syn and syn + plaque morphology variants of the wild type HSV-I strain 17, were used. From the test plates twenty-five well-defined plaques were picked, inoculated on to 5o mm Petri plates in the absence of the inhibitor and the resulting I46 Short communications progeny re-tested in plaque assay in the presence or absence of Ioo #g/ml PPA. Six of the original 25 PPA-resistant plaques yielded virus which clearly grew better than the starting stock in the presence of PPA; three of these spontaneous potential mutants were chosen for further study: mutant I9 from HSV-2, mutant 3 from HSV-I syn + and mutant 14 from HSV-I syn. After a re-test had confirmed the genetic nature of the PPA resistance, the mutants were grown to high titre by low multiplicity infection of BHK cells in the absence of inhibitor. All three gave yields comparable with that of wild-type virus. Finally, these three stocks were re-tested for resistance; the titre obtained for each of the mutants in BHK cells in the presence and absence of IOO #g/ml PPA was not significantly different, although in all cases the plaques were somewhat smaller in the presence of PPA. (This reduced plaque size may reflect the effect of this concentration of PPA on the host BHK cells -uninfected controls showed some reduction in cell growth in the presence of Ioo #g/ml PPA over 48 to 72 h.) 5o mm Petri dishes of BHK cells were infected in pairs with Io p.f.u./cell of HSV-I wildtype or mutant 3, or HSV-2 wild-type or mutant 19, or were mock-infected. A duplicate set of plates contained Ioo#g/ml PPA. After 2 h, io #Ci/plate [3H]-dThd was added and incubation continued at 36 °C for a further 22 h. The plates were then washed with saline and the cells removed in 2 ~ SDS before overnight incubation at 36 °C with 5oo #g/ml pronase, Solid CsC1 was added and cell and virus DNAs separated by centrifugation. The results (not shown) indicate that, while mock-infected cell DNA synthesis is inhibited to a small extent by PPA at that concentration, formation of viral DNA in wild-type virus infected cells is depressed by more than 75 ~-In contrast, both mutants exhibited essentially the same amount of viral DNA synthesis in the presence and absence of PPA.
Nuclei isolated from BHK cells infected with either HSV-t or HSV-2 have been shown to be capable of forming cell and virus DNA in vitro in relative quantities rather similar to infected whole cells (J. Hay & A. Weissbach, unpublished observations) . Accordingly, BHK cells were infected at Io p.f.u./cell with wild-type HSV-I or 2 or the mutants 3 or I9. After 7 h at 36 °C, nuclei were isolated (Berkowitz, Kakefuda & Sporn, i969) and incubated with increasing concentrations of PPA, using [3H]-TTP as label as descrilzed by Bolden, Aucker & Weissbach (1975) . Samples were acid-precipitated and washed before counting in a scintillation spectrometer.
The results (Fig. I) indicate that, while both wild-type-infected nuclei are sensitive, mock-infected or mutant-infected nuclei are resistant to PPA except at higher concentrations. This supports the earlier observation made in whole cells, but in the isolated nuclei viral DNA synthesis is sensitive to much lower concentrations of PPA than in vivo. (This may reflect difficulty of entry for PPA into intact cells.) Samples from this last experiment analysed as above on CsC1 gradients, showed that wild-type viral DNA synthesis was much more seriously affected than cell DNA synthesis in the presence of PPA.
BHK cells were infected with wild-type HSV-I or HSV-2, or mutants 3, I9 or x4 at IO p.f.u./cell or mock-infected for 7 h at 36 °C. Crude extracts were made and assayed for DNA polymerase activity with denatured or activated calf-thymus DNA at I5o mM-KC1 for infected samples and 3o mM-KC1 for mock-infected samples, essentially by the method of Keir et al. (1966) .
A range of concentrations of PPA was added to the assay mixture and the results are given in Fig. 2 . Both wild-type HSV-I and HSV-2 DNA polymerase activities are strongly inhibited by PPA, a concentration of only I #g/ml resulting in a 7o to 75 ~ fall in activity. This degree of inhibition is similar to that reported for a partially-purified DNA polymerase activity from HSV-I infected WI38 cells (Mao et al. 1975) . As indicated by the above authors for partially purified WI38 extracts, the crude preparation of DNA polymerases from BHK cells is only slightly affected by PPA, at least at concentrations up to 5/~g/ml. There clearly is inhibition at higher concentrations (Fig. 2) , and it would be interesting to separate the BHK DNA polymerases and examine them individually. The viral DNA polymerase activities from cells infected with mutants 3, x9 or I4 are also inhibited by PPA, but to a much smaller extent than wild-type. For example, PPA at I #g/ml causes only about 2o ~ inhibition of mutant enzyme and at ~o #g/ml only a small amount of wild-tYFe activity remains as against 25 to 3o ~ of mutant activity (Fig. 2) .
These results show first that HSV-L strain ]7 and HSV-2, strain HG52, are growthinhibited by PPA, and this inhibition can be traced to impaired viral DNA synthesis both in vivo and in an isolated nuclear system; this appears to be PPA mediated inhibition of the viral DNA polymerase activity. Some of these data confirm the earlier observations of Mao et al. (~975) .
In addition, it has been demonstrated that mutants of both types of HSV and of both syn and syn + morphology can be selected for resistance to PPA; cells infected with such mutants can be shown to produce plaques and synthesise viral DNA in vivo and in isolated nuclei, in the presence of concentrations of PPA totally inhibitory to wild-type virus. Moreover, the viral DNA polymerase activity induced by resistant mutants shows resistance to PPA in vitro. It seems reasonable to suggest, therefore, that the genetic change to produce the three PPA-resistant HSV mutants is in each case an alteration in a (the) structural gene for DNA polymerase. Although other, less likely explanations such as induction of PPAresistant cell DNA polymerases cannot be excluded and are being tested. This work supports, by independent criteria, the suggestion that at least one polypeptide component of the viral DNA polymerase is virus-coded and essential for viral DNA synthesis.
Attempts have been made to obtain mutants resistant to levels of PPA higher than these used in this study. However, as discussed earlier, the cell lines we routinely used are killed at high PPA concentrations. Selection of cell lines able to grow in higher concentrations of PPA is in progress and results are encouraging; when these cells are available in quantity it will be attempted to isolate single and multiple-step HSV mutants with enhanced resistance to PPA.
The ready isolation of spontaneously occurring or pre-existing PPA resistant mutants calls for caution in plans to employ this compound in a clinical situation.
